1.
Suryanarayana Rao K. Preclinical Safety Considerations for Biosimilars. BEMS Reports [Internet]. 2017Jul.1 [cited 2024Mar.28];3(2):67-9. Available from: https://bemsreports.org/index.php/bems/article/view/82